Nocturnal synchronization between hippocampal ripples and cortical delta power is a biomarker of hippocampal epileptogenicity

Takamitsu Iwata,Takufumi Yanagisawa,Ryohei Fukuma,Yuji Ikegaya,Satoru Oshino,Naoki Tani,Hui Ming Khoo,Hidenori Sugano,Yasushi Iimura,Hiroharu Suzuki,Haruhiko Kishima

DOI: https://doi.org/10.1101/2024.06.05.24308489

2024-06-05

Abstract:Objective: Hippocampal ripples are biomarkers of epileptogenicity in patients with epilepsy, and physiological features characterize memory function in healthy individuals. Discriminating between pathological and physiological ripples is important for identifying the epileptogenic (EP) zone; however, distinguishing them from waveforms is difficult. This study hypothesized that the nocturnal synchronization of hippocampal ripples and cortical delta power classifies EP and physiological hippocampi. Methods: We enrolled 38 patients with electrodes implanted in the hippocampus or the parahippocampal gyrus between April 2014 and March 2023 at our institution. We classified 11 patients (11 hippocampi) into the EP group, who were pathologically diagnosed with hippocampal sclerosis, and five patients (six hippocampi) into the non-epileptogenic (NE) group, whose hippocampi had no epileptogenicity. Hippocampal ripples were detected using intracranial electroencephalography of the hippocampal or parahippocampal electrodes and presented as ripple rates per second. Cortical delta power (0.5-4 Hz) was assessed using cortical electrodes. The Pearson correlation coefficient between the ripple rates and the cortical delta power (CRD) was calculated for the intracranial electroencephalographic signals obtained every night during the recordings. Results: Hippocampal ripples detected from continuous recording for approximately 10 days demonstrated similar frequency characteristics between the EP and NE groups. However, CRDs in the EP group (mean [standard deviation]: 0.20 [0.049]) were significantly lower than those in the NE group (0.67 [0.070], F (1,124) = 29.6, p < 0.0001 (group), F (9,124) = 1.0, p = 0.43 (day); two-way analysis of variance). Based on the minimum CRDs during the 10-day recordings, the two groups were classified with 94.1% accuracy. Conclusion: CRD is a biomarker of hippocampal epileptogenicity.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to distinguish the epileptogenic (EP) and non - epileptogenic (NE) hippocampus through the synchrony between nocturnal hippocampal ripples and cortical delta - wave power. Specifically, the study hypothesizes that if the hippocampal ripples are affected by pathological ripples, the nocturnal synchrony between these ripples and cortical delta - wave power will be reduced. This finding can be used as a biomarker for identifying hippocampal epileptogenicity, thereby helping to accurately locate the epileptic seizure source and improve the effectiveness of surgical treatment and the accuracy of prognostic assessment.

The paper mentions that high - frequency oscillations (HFOs) are biomarkers of epileptic sources or pathological tissues, but distinguishing between physiological and pathological HFOs is crucial for accurately assessing patients' electroencephalogram (EEG) signals, which is somewhat difficult in clinical practice. Therefore, the researchers explored the relationship between hippocampal ripples and cortical delta - wave power in the hope of finding a new method to identify pathological activities in the hippocampus, especially hippocampal sclerosis, which is a common pathological state leading to drug - resistant temporal lobe epilepsy. By analyzing the data recorded by long - term implanted electrodes in patients, the researchers found that the correlation coefficient (CRD) between hippocampal ripples and cortical delta - wave power in the EP group was significantly lower than that in the NE group, and hippocampal sclerosis could be predicted with 94.1% accuracy based on the lowest CRD value. This indicates that CRD can be used as an effective biomarker for assessing hippocampal epileptogenicity.